Por: Fox News Entertainment September 21, 2023
announced that he is relearning how to walk after being diagnosed with Guillain-Barré syndrome, a rare autoimmune disease. Stevens — whose first name is pronounced SOOF-yawn — announced the news The 48-year-old musician explained why he was unable to promote his newest album Javelin, which is set to be released Oct. 6.Last month I woke up one morning and couldn’t walk, the Chicago singer wrote in a post. My hands, arms and legs were numb... + full article
CBS News USA Entertainment September 21, 2023
Singer Sufjan Stevens is on the mend after being diagnosed with the rare autoimmune disorder .The Grammy and Oscar-nominated musician shared an update with his fans on his Wednesday explaining why he hasn't been able to participate in the promotion of his latest album,... + más
FDA says Guillain-Barre syndrome is possible risk of Pfizer's RSV vaccine for older adults | CNBC
Sufjan Stevens is relearning to walk after Guillain-Barre Syndrome left him immobile, hospitalized | ABC News
Los Angeles Times USA Entertainment September 20, 2023
Singer-songwriter Sufjan Stevens revealed Wednesday that he has been hospitalized due to being diagnosed with the autoimmune disorder Guillain-Barré syndrome. Stevens shared the news with his fans in a post on his website on Wednesday morning. Last month I woke up one morning... + más
Singer Sufjan Stevens relearning to walk after Guillain-Barré syndrome diagnosis | CBS News
ABC News USA Entertainment September 20, 2023
LOS ANGELES -- Grammy- and Oscar-nominated indie musician Sufjan Stevens is relearning how to walk after the autoimmune disease Guillain-Barre Syndrome left him immobile, representatives confirmed to The Associated Press. On Wednesday, Steven shared the news on his Tumblr page.... + más
ABC News USA Tech September 20, 2023
CNBC USA Health March 01, 2023
Blood sample for respiratory syncytial virus (RSV) testJarun011 Istock Getty ImagesThe Food and Drug Administration's independent advisors on Tuesday recommended what would be the world's first RSV vaccine, a shot from for adults ages 60 and older, despite safety... + más
FDA warns of Guillain-Barre syndrome as possible risk of Pfizer’s RSV vaccine | New York Daily News
New York Daily News USA Nation February 25, 2023
The Food and Drug Administration has flagged Guillain-Barre syndrome, a rare neurological condition, as a potential risk for Pfizer’s respiratory syncytial virus (RSV) vaccine. Two people in their 60s who received the shot were diagnosed with Guillain-Barre syndrome, out of... + más
FDA advisors recommend first-ever RSV vaccine from Pfizer, despite possible Guillain-Barre risks | CNBC
CNBC USA Health February 24, 2023
In this articleThis 1981 photo provided by the Centers for Disease Control and Prevention (CDC) shows an electron micrograph of Respiratory Syncytial Virus, also known as RSV.CDC via APThe Food and Drug Administration sees a possible risk of Guillain-Barre syndrome with 's... + más
RSV vaccine: FDA advisers vote in favor of approval for vaccines for older adults | ABC7
About iurex | Privacy Policy | Disclaimer |